Pub Date : 2022-02-15Epub Date: 2021-12-15DOI: 10.11613/BM.2022.010704
Pieter-Jan Briers, Michel R Langlois
Introduction: Two new formulas, the Martin-Hopkins and the Sampson formula, were recently developed to overcome shortcomings of the Friedewald formula for calculating LDL-cholesterol. We aimed to compare the concordance of the two formulas with apolipoprotein B (apoB), a surrogate marker of the number of LDL particles.
Materials and methods: In a study of serum lipid data of 1179 patients who consulted the AZ St-Jan Hospital Bruges for cardiovascular risk assessment, the correlation and concordance of the Friedewald, Martin-Hopkins and Sampson formulas with apoB concentration, measured by immunonephelometry, were determined and compared.
Results: The Martin-Hopkins formula showed significantly higher correlation coefficient than the Friedewald formula with apoB in the entire dataset and in patients with low LDL-cholesterol < 1.8 mmol/L. Both Martin-Hopkins and Sampson formulas yielded > 70% concordance of LDL-cholesterol with regard to treatment group classification based on population-equivalent thresholds of apoB in hypertriglyceridemic patients (2-4.5 mmol/L), with the highest concordance (75.6%) obtained using Martin-Hopkins formula vs. 60.5% with Friedewald formula.
Conclusion: The Martin-Hopkins (and, to a lesser extent, Sampson) formula is more closely associated with the number of LDL particles than Friedewald formula. This, in combination with literature evidence of lesser accuracy of the Friedewald formula, is an argument to switch from Friedewald to a modified, improved formula.
介绍:两个新的公式,马丁-霍普金斯和桑普森公式,最近发展克服了计算低密度脂蛋白胆固醇的弗里德瓦尔德公式的缺点。我们的目的是比较两种配方与载脂蛋白B (apoB)的一致性,载脂蛋白B是LDL颗粒数量的替代标记物。材料与方法:对1179例就诊于Bruges AZ St-Jan医院进行心血管风险评估的患者的血脂数据进行研究,确定并比较Friedewald、Martin-Hopkins和Sampson配方与免疫比浊法测定的载脂蛋白ob浓度的相关性和一致性。结果:在整个数据集和低ldl -胆固醇< 1.8 mmol/L的患者中,Martin-Hopkins公式与载脂蛋白ob的相关系数显著高于Friedewald公式。根据高甘油三酯血症患者(2-4.5 mmol/L)载脂蛋白ob的人群等效阈值进行治疗组分类时,Martin-Hopkins和Sampson公式的ldl -胆固醇一致性均> 70%,其中Martin-Hopkins公式的一致性最高(75.6%),而Friedewald公式的一致性最高(60.5%)。结论:与Friedewald公式相比,Martin-Hopkins公式(在较小程度上,Sampson公式)与LDL颗粒数量的关系更为密切。这一点,再加上弗里德瓦尔德公式准确性较低的文献证据,是一个从弗里德瓦尔德公式转向一个修改的、改进的公式的理由。
{"title":"Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol.","authors":"Pieter-Jan Briers, Michel R Langlois","doi":"10.11613/BM.2022.010704","DOIUrl":"https://doi.org/10.11613/BM.2022.010704","url":null,"abstract":"<p><strong>Introduction: </strong>Two new formulas, the Martin-Hopkins and the Sampson formula, were recently developed to overcome shortcomings of the Friedewald formula for calculating LDL-cholesterol. We aimed to compare the concordance of the two formulas with apolipoprotein B (apoB), a surrogate marker of the number of LDL particles.</p><p><strong>Materials and methods: </strong>In a study of serum lipid data of 1179 patients who consulted the AZ St-Jan Hospital Bruges for cardiovascular risk assessment, the correlation and concordance of the Friedewald, Martin-Hopkins and Sampson formulas with apoB concentration, measured by immunonephelometry, were determined and compared.</p><p><strong>Results: </strong>The Martin-Hopkins formula showed significantly higher correlation coefficient than the Friedewald formula with apoB in the entire dataset and in patients with low LDL-cholesterol < 1.8 mmol/L. Both Martin-Hopkins and Sampson formulas yielded > 70% concordance of LDL-cholesterol with regard to treatment group classification based on population-equivalent thresholds of apoB in hypertriglyceridemic patients (2-4.5 mmol/L), with the highest concordance (75.6%) obtained using Martin-Hopkins formula <i>vs</i>. 60.5% with Friedewald formula.</p><p><strong>Conclusion: </strong>The Martin-Hopkins (and, to a lesser extent, Sampson) formula is more closely associated with the number of LDL particles than Friedewald formula. This, in combination with literature evidence of lesser accuracy of the Friedewald formula, is an argument to switch from Friedewald to a modified, improved formula.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"010704"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39851746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrea Tešija Kuna, Lovorka Đerek, Vedrana Drvar, Ana Kozmar, Katarina Gugo
[This corrects the article DOI: 10.11613/BM.2021.020502.].
[更正文章DOI: 10.11613/BM.2021.020502.]。
{"title":"Corrigendum to: Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine.","authors":"Andrea Tešija Kuna, Lovorka Đerek, Vedrana Drvar, Ana Kozmar, Katarina Gugo","doi":"10.11613/BM.2022.011201","DOIUrl":"https://doi.org/10.11613/BM.2022.011201","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.11613/BM.2021.020502.].</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"011201"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39670810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Automated erythrocyte sedimentation rate (ESR) analysers are based on different methodology than Westergren method. It is questionable whether ESR values obtained from those analysers are comparable with determined values with Westergren method. The aim was verification of the precision, method comparison and accuracy of automated ESR analysers: Roller 20PN (Alifax S.p.A., Polverara, Italy) and iSED (Alcor Scientific, Smithfield, USA).
Materials and methods: Blood samples (N = 752 for Roller 20PN and N = 213 for iSED) were sampled into K2EDTA (Kima, Italy) tubes for automated and 3.8% Na-citrate tubes (Kima, Italy) for Westergren method. The data was divided into three groups according to the ESR values obtained with the Westergren method: Group Low (L) (ESR ≤ 20 mm), Group Medium (M) (ESR 21-60 mm), and Group High (H) (ESR ≥ 61 mm). Method agreement was assessed by Bland-Altman analysis and Passing-Bablok regression.
Results: Analyser iSED has shown better comparability with Westergren method (bias 0.0 (95%Cl -1.4 to 1.5) range than Roller 20 PN (bias = - 6.4 (95%Cl - 7.1 to -5.7) in the whole measuring. For Roller 20 PN, Passing-Bablok regression has shown constant and proportional difference for Groups L and M, and for iSED only for Group H. Roller 20 PN had lower sensitivity (0.51 (95%Cl: 0.45-0.57) than iSED (0.72 (95%Cl: 0.59-0.80) while they had comparable specificity (> 0.90) and accuracy (≥ 0.80) in comparison with the Westergren method.
Conclusion: Both analysers are not comparable with the Westergren method and should not be used interchangeably.
{"title":"Verification of automatic analysers Roller 20PN and iSED for measuring erythrocyte sedimentation rate.","authors":"Helena Čičak, Pavica Šonjić, Ana-Maria Šimundić","doi":"10.11613/BM.2022.010708","DOIUrl":"https://doi.org/10.11613/BM.2022.010708","url":null,"abstract":"<p><strong>Introduction: </strong>Automated erythrocyte sedimentation rate (ESR) analysers are based on different methodology than Westergren method. It is questionable whether ESR values obtained from those analysers are comparable with determined values with Westergren method. The aim was verification of the precision, method comparison and accuracy of automated ESR analysers: Roller 20PN (Alifax S.p.A., Polverara, Italy) and iSED (Alcor Scientific, Smithfield, USA).</p><p><strong>Materials and methods: </strong>Blood samples (N = 752 for Roller 20PN and N = 213 for iSED) were sampled into K<sub>2</sub>EDTA (Kima, Italy) tubes for automated and 3.8% Na-citrate tubes (Kima, Italy) for Westergren method. The data was divided into three groups according to the ESR values obtained with the Westergren method: Group Low (L) (ESR ≤ 20 mm), Group Medium (M) (ESR 21-60 mm), and Group High (H) (ESR ≥ 61 mm). Method agreement was assessed by Bland-Altman analysis and Passing-Bablok regression.</p><p><strong>Results: </strong>Analyser iSED has shown better comparability with Westergren method (bias 0.0 (95%Cl -1.4 to 1.5) range than Roller 20 PN (bias = - 6.4 (95%Cl - 7.1 to -5.7) in the whole measuring. For Roller 20 PN, Passing-Bablok regression has shown constant and proportional difference for Groups L and M, and for iSED only for Group H. Roller 20 PN had lower sensitivity (0.51 (95%Cl: 0.45-0.57) than iSED (0.72 (95%Cl: 0.59-0.80) while they had comparable specificity (> 0.90) and accuracy (≥ 0.80) in comparison with the Westergren method.</p><p><strong>Conclusion: </strong>Both analysers are not comparable with the Westergren method and should not be used interchangeably.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"010708"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39834173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-15Epub Date: 2021-12-15DOI: 10.11613/BM.2022.010903
Ivana Lapić, Dunja Rogić, Nora Nikolac Gabaj, Katarina Kajić, Nena Peran, Lada Surjan, Anamarija Đuras, Valentina Cesar Kocijan, Nada Bilopavlović, Fran Smaić, Mario Štefanović, Ivanka Ostroški, Leida Tandara, Milena Krnjaić-Tadijanović, Ivan Gornik, Hrvoje Pintarić, Daniela Marasović Krstulović, Blaženka Miškić, Dario Rahelić
Introduction: Based on the hypothesis that there is a substantial rate of adults with prediabetes and undiagnosed diabetes mellitus (DM), our aim was to perform haemoglobin A1c (HbA1c)-based screening in a cohort of Croatian adults and estimate the prevalence of prediabetes and undiagnosed DM according to American Diabetes Association criteria.
Materials and methods: This multi-center, cross-sectional study performed in six Croatian hospitals included 5527 patients aged 40 to 70 years admitted to the Emergency Department or undergoing a primary care check-up. Haemoglobin A1c was measured from leftover whole blood samples using the enzymatic method on either Alinity c or Architect c-series analyser (Abbott Laboratories, Chicago, USA). Haemoglobin A1c between 39-47 mmol/mol was classified as prediabetes, while ≥ 48 mmol/mol as undiagnosed DM.
Results: After exclusion of 435 patients with known DM, the final cohort included 5092 patients (median age 57; 56% males). A total of 882 (17.3%) patients had HbA1c values between 39 and 47 mmol/mol. There were 214 (4.2%) patients with HbA1c ≥ 48 mmol/mol. Prediabetes prevalence ranged from 14.2% to 20.5%, while undiagnosed DM from 3.3% to 7.3%, with statistically significant differences among settings (P < 0.001). Age-stratified analysis showed that prediabetes and undiagnosed DM prevalence increase with age (P < 0.001), being 25.4% and 5.8%, respectively, in patients aged 60 to 70 years.
Conclusion: Underlying impairment of glucose metabolism was identified in about one in five adults, with significant number of patients with already overt DM. These results should serve as a starting point for further steps directed towards promotion of preventive measures for DM in Croatia.
{"title":"Haemoglobin A1c-based screening for prediabetes and diabetes mellitus: a multi-center study in Croatian adult population.","authors":"Ivana Lapić, Dunja Rogić, Nora Nikolac Gabaj, Katarina Kajić, Nena Peran, Lada Surjan, Anamarija Đuras, Valentina Cesar Kocijan, Nada Bilopavlović, Fran Smaić, Mario Štefanović, Ivanka Ostroški, Leida Tandara, Milena Krnjaić-Tadijanović, Ivan Gornik, Hrvoje Pintarić, Daniela Marasović Krstulović, Blaženka Miškić, Dario Rahelić","doi":"10.11613/BM.2022.010903","DOIUrl":"https://doi.org/10.11613/BM.2022.010903","url":null,"abstract":"<p><strong>Introduction: </strong>Based on the hypothesis that there is a substantial rate of adults with prediabetes and undiagnosed diabetes mellitus (DM), our aim was to perform haemoglobin A1c (HbA<sub>1c</sub>)-based screening in a cohort of Croatian adults and estimate the prevalence of prediabetes and undiagnosed DM according to American Diabetes Association criteria.</p><p><strong>Materials and methods: </strong>This multi-center, cross-sectional study performed in six Croatian hospitals included 5527 patients aged 40 to 70 years admitted to the Emergency Department or undergoing a primary care check-up. Haemoglobin A1c was measured from leftover whole blood samples using the enzymatic method on either Alinity c or Architect c-series analyser (Abbott Laboratories, Chicago, USA). Haemoglobin A1c between 39-47 mmol/mol was classified as prediabetes, while ≥ 48 mmol/mol as undiagnosed DM.</p><p><strong>Results: </strong>After exclusion of 435 patients with known DM, the final cohort included 5092 patients (median age 57; 56% males). A total of 882 (17.3%) patients had HbA<sub>1c</sub> values between 39 and 47 mmol/mol. There were 214 (4.2%) patients with HbA<sub>1c</sub> ≥ 48 mmol/mol. Prediabetes prevalence ranged from 14.2% to 20.5%, while undiagnosed DM from 3.3% to 7.3%, with statistically significant differences among settings (P < 0.001). Age-stratified analysis showed that prediabetes and undiagnosed DM prevalence increase with age (P < 0.001), being 25.4% and 5.8%, respectively, in patients aged 60 to 70 years.</p><p><strong>Conclusion: </strong>Underlying impairment of glucose metabolism was identified in about one in five adults, with significant number of patients with already overt DM. These results should serve as a starting point for further steps directed towards promotion of preventive measures for DM in Croatia.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"32 1","pages":"010903"},"PeriodicalIF":3.3,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39851750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: The detection and prevention of errors in the postanalytical phase can be done through the harmonization and standardization of constituent parts of this phase of laboratory work. The aim was to investigate how well the ongoing management of the postanalytical phase corresponds to the document "Post-analytical laboratory work: national recommendations" in Croatian medical biochemistry laboratories (MBLs).
Materials and methods: All 195 MBLs participating in the national external quality assessment scheme, were invited to undertake a part in a survey. Through 23 questions the participants were asked about management of the reference intervals (RI), delta check, reflex/reflective testing, postanalytical quality indicators and other parts of the postanalytical phase recommended in the national recommendations. The results are presented in numbers and percentages.
Results: Out of 195 MBLs, 119 participated in the survey, giving a response rate of 61%. Not all of the respondents provided answers to all the questions. Delta check has not been used in 59% (70/118) of the laboratories. Only 22/113 (20%) laboratories use reflex and/or reflective testing. In 53% of the laboratories, critical results were reported within 30 minutes of the confirmation of the results. In 34% (40/118) of the laboratories, turnaround time and reporting of critical results are two most often monitored postanalytical quality indicators.
Conclusion: The results showed the critical results reporting and monitoring of postanalytical quality indicators are in the line with the recommendations. However, the management of RI verification, the use of delta check and reflex/reflective testing still must be harmonized among Croatian MBLs.
{"title":"The concurrence of the current postanalytical phase management with the national recommendations: a survey of the Working Group for Postanalytics of the Croatian Society of Medical Biochemistry and Laboratory Medicine.","authors":"Anja Jokic, Vladimira Rimac, Jelena Vlasic Tanaskovic, Sonja Podolar, Lorena Honovic, Jasna Lenicek Krleza","doi":"10.11613/BM.2021.030704","DOIUrl":"https://doi.org/10.11613/BM.2021.030704","url":null,"abstract":"<p><strong>Introduction: </strong>The detection and prevention of errors in the postanalytical phase can be done through the harmonization and standardization of constituent parts of this phase of laboratory work. The aim was to investigate how well the ongoing management of the postanalytical phase corresponds to the document \"Post-analytical laboratory work: national recommendations\" in Croatian medical biochemistry laboratories (MBLs).</p><p><strong>Materials and methods: </strong>All 195 MBLs participating in the national external quality assessment scheme, were invited to undertake a part in a survey. Through 23 questions the participants were asked about management of the reference intervals (RI), delta check, reflex/reflective testing, postanalytical quality indicators and other parts of the postanalytical phase recommended in the national recommendations. The results are presented in numbers and percentages.</p><p><strong>Results: </strong>Out of 195 MBLs, 119 participated in the survey, giving a response rate of 61%. Not all of the respondents provided answers to all the questions. Delta check has not been used in 59% (70/118) of the laboratories. Only 22/113 (20%) laboratories use reflex and/or reflective testing. In 53% of the laboratories, critical results were reported within 30 minutes of the confirmation of the results. In 34% (40/118) of the laboratories, turnaround time and reporting of critical results are two most often monitored postanalytical quality indicators.</p><p><strong>Conclusion: </strong>The results showed the critical results reporting and monitoring of postanalytical quality indicators are in the line with the recommendations. However, the management of RI verification, the use of delta check and reflex/reflective testing still must be harmonized among Croatian MBLs.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030704"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495617/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-10-15Epub Date: 2021-08-05DOI: 10.11613/BM.2021.030702
Adriana Bokulić, Ivana Zec, Domagoj Marijančević, Sanja Goreta, Marija Požgaj Šepec, Lavinia La Grasta Sabolić
Introduction: Evaluation of thyroid function is often requested and therefore defining paediatric reference intervals (RIs) is of vital importance. Currently, there is a distinct lack of paediatric RIs for thyroid function tests in Croatia. Thus, we established RIs for thyroid stimulating hormone (TSH), total triiodothyronine (TT3), total thyroxine (TT4), free triiodothyronine (FT3) and free thyroxine (FT4) in the Croatian paediatric population.
Materials and methods: Reference intervals were calculated from 397 apparently healthy children, aged from 2 days to < 19 years. Serum samples were analysed for thyroid function tests on the Abbott Architect i2000. Age- and sex-specific 95% RIs with 90% confidence intervals were established according to Clinical and Laboratory Standards Institute guidelines. To express the magnitude of sex and age variation, standard deviation ratio (SDR) was calculated using two-level nested ANOVA. The criterion for considering partitioning reference values was set to SDR > 0.3.
Results: All thyroid function tests required age partitioning, confirmed by SDR above 0.3. There was no need for sex partitioning, confirmed by SDR below 0.3. Still, FT3 was partitioned due to visually noticeable sex related difference for the oldest group (12 years to < 19 years).
Conclusion: This is the first study to establish RIs for thyroid function tests in the Croatian paediatric population. We propose RIs for widely used Abbott platform, thus giving laboratories method- and population-specific paediatric RIs for thyroid function tests that should improve clinical test interpretation.
{"title":"Establishing paediatric reference intervals for thyroid function tests in Croatian population on the Abbott Architect i2000.","authors":"Adriana Bokulić, Ivana Zec, Domagoj Marijančević, Sanja Goreta, Marija Požgaj Šepec, Lavinia La Grasta Sabolić","doi":"10.11613/BM.2021.030702","DOIUrl":"https://doi.org/10.11613/BM.2021.030702","url":null,"abstract":"<p><strong>Introduction: </strong>Evaluation of thyroid function is often requested and therefore defining paediatric reference intervals (RIs) is of vital importance. Currently, there is a distinct lack of paediatric RIs for thyroid function tests in Croatia. Thus, we established RIs for thyroid stimulating hormone (TSH), total triiodothyronine (TT3), total thyroxine (TT4), free triiodothyronine (FT3) and free thyroxine (FT4) in the Croatian paediatric population.</p><p><strong>Materials and methods: </strong>Reference intervals were calculated from 397 apparently healthy children, aged from 2 days to < 19 years. Serum samples were analysed for thyroid function tests on the Abbott Architect i2000. Age- and sex-specific 95% RIs with 90% confidence intervals were established according to Clinical and Laboratory Standards Institute guidelines. To express the magnitude of sex and age variation, standard deviation ratio (SDR) was calculated using two-level nested ANOVA. The criterion for considering partitioning reference values was set to SDR > 0.3.</p><p><strong>Results: </strong>All thyroid function tests required age partitioning, confirmed by SDR above 0.3. There was no need for sex partitioning, confirmed by SDR below 0.3. Still, FT3 was partitioned due to visually noticeable sex related difference for the oldest group (12 years to < 19 years).</p><p><strong>Conclusion: </strong>This is the first study to establish RIs for thyroid function tests in the Croatian paediatric population. We propose RIs for widely used Abbott platform, thus giving laboratories method- and population-specific paediatric RIs for thyroid function tests that should improve clinical test interpretation.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030702"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39311867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Mrzljak, Željka Jureković, Jadranka Pavičić-Šarić, Vladimir Stevanović, Irena Tabain, Željka Hruškar, Danko Mikulić, Ljubo Barbić, Tatjana Vilibić-Čavlek
Introduction: The data on the coronavirus disease (COVID-19) in solid-organ transplant recipients (SOTRs) in Croatia is unknown. The aim of this study was to analyze the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Croatian SOTRs.
Materials and methods: From 7 September to 27 November 2020 (beginning of the second COVID-19 pandemic wave), a cross-sectional screening for COVID-19 was performed in the adult outpatient liver (LTRs; N = 280) and kidney transplant recipients (KTRs; N = 232). Serum samples were initially tested for SARS-CoV-2 IgG antibodies using a commercial enzyme-linked immunosorbent assay (ELISA; Vircell Microbiologists, Granada, Spain). All positive samples were confirmed using a virus neutralization test (VNT). Data on risk exposure and COVID-19 related symptoms were collected using a questionnaire.
Results: The transplanted cohort's seroprevalence detected by ELISA and VNT was 20.1% and 3.1%, respectively. Neutralizing (NT) antibodies developed in 15.6% of anti-SARS-CoV-2 ELISA IgG positive SOTRs. The difference in seropositivity rates between LTRs and KTRs was not statistically significant (ELISA 21.1% vs. 19.0%, P = 0.554; VNT 3.6% vs. 2.6%, P = 0.082). Overall VNT positivity rates were higher in patients who reported participation in large community events (5.9% vs. 1.0%; P = 0.027) as well as in patients who reported COVID-19 related symptoms in the past six months. In addition, symptomatic VNT positive patients showed significantly higher (P = 0.031) NT antibody titers (median 128, interquartile range (IQR) = 32-128) compared to asymptomatic patients (median 16, IQR = 16-48).
Conclusions: This study showed that 15.6% of anti-SARS-CoV-2 ELISA positive Croatian SOTRs developed NT antibodies indicating protective immunity. Further studies are needed to determine the dynamic of NT antibodies and COVID-19 immunity duration in immunocompromised populations such as LTRs and KTRs.
克罗地亚实体器官移植受者(SOTRs)中冠状病毒病(COVID-19)的数据尚不清楚。本研究的目的是分析克罗地亚sotr中严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)的血清患病率。材料和方法:2020年9月7日至11月27日(第二波COVID-19大流行开始),对成人门诊肝脏(lts)进行COVID-19横断面筛查;N = 280)和肾移植受者(KTRs;N = 232)。使用商用酶联免疫吸附试验(ELISA)对血清样本进行SARS-CoV-2 IgG抗体的初步检测;Vircell微生物学家,格拉纳达,西班牙)。所有阳性样本均采用病毒中和试验(VNT)进行确认。使用问卷收集风险暴露和COVID-19相关症状的数据。结果:ELISA和VNT检测移植队列血清阳性率分别为20.1%和3.1%。在15.6%的抗sars - cov -2 ELISA IgG阳性sotr中产生中和抗体。LTRs与KTRs血清阳性率差异无统计学意义(ELISA 21.1% vs. 19.0%, P = 0.554;VNT 3.6% vs. 2.6%, P = 0.082)。报告参加大型社区活动的患者VNT总体阳性率较高(5.9% vs 1.0%;P = 0.027),以及在过去6个月内报告有COVID-19相关症状的患者。此外,有症状的VNT阳性患者的NT抗体滴度(中位数128,四分位间距(IQR) = 32-128)明显高于无症状患者(中位数16,IQR = 16-48) (P = 0.031)。结论:本研究显示,15.6%的抗sars - cov -2 ELISA阳性的克罗地亚SOTRs产生NT抗体,表明具有保护性免疫。在ltr和ktr等免疫功能低下人群中,NT抗体动态和COVID-19免疫持续时间有待进一步研究。
{"title":"Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.","authors":"Anna Mrzljak, Željka Jureković, Jadranka Pavičić-Šarić, Vladimir Stevanović, Irena Tabain, Željka Hruškar, Danko Mikulić, Ljubo Barbić, Tatjana Vilibić-Čavlek","doi":"10.11613/BM.2021.030901","DOIUrl":"https://doi.org/10.11613/BM.2021.030901","url":null,"abstract":"<p><strong>Introduction: </strong>The data on the coronavirus disease (COVID-19) in solid-organ transplant recipients (SOTRs) in Croatia is unknown. The aim of this study was to analyze the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Croatian SOTRs.</p><p><strong>Materials and methods: </strong>From 7 September to 27 November 2020 (beginning of the second COVID-19 pandemic wave), a cross-sectional screening for COVID-19 was performed in the adult outpatient liver (LTRs; N = 280) and kidney transplant recipients (KTRs; N = 232). Serum samples were initially tested for SARS-CoV-2 IgG antibodies using a commercial enzyme-linked immunosorbent assay (ELISA; Vircell Microbiologists, Granada, Spain). All positive samples were confirmed using a virus neutralization test (VNT). Data on risk exposure and COVID-19 related symptoms were collected using a questionnaire.</p><p><strong>Results: </strong>The transplanted cohort's seroprevalence detected by ELISA and VNT was 20.1% and 3.1%, respectively. Neutralizing (NT) antibodies developed in 15.6% of anti-SARS-CoV-2 ELISA IgG positive SOTRs. The difference in seropositivity rates between LTRs and KTRs was not statistically significant (ELISA 21.1% <i>vs</i>. 19.0%, P = 0.554; VNT 3.6% <i>vs</i>. 2.6%, P = 0.082). Overall VNT positivity rates were higher in patients who reported participation in large community events (5.9% <i>vs</i>. 1.0%; P = 0.027) as well as in patients who reported COVID-19 related symptoms in the past six months. In addition, symptomatic VNT positive patients showed significantly higher (P = 0.031) NT antibody titers (median 128, interquartile range (IQR) = 32-128) compared to asymptomatic patients (median 16, IQR = 16-48).</p><p><strong>Conclusions: </strong>This study showed that 15.6% of anti-SARS-CoV-2 ELISA positive Croatian SOTRs developed NT antibodies indicating protective immunity. Further studies are needed to determine the dynamic of NT antibodies and COVID-19 immunity duration in immunocompromised populations such as LTRs and KTRs.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030901"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-10-15Epub Date: 2021-08-05DOI: 10.11613/BM.2021.030201
Nicole Shu Ling Yeo-Teh, Bor Luen Tang
A predatory journal could be provisionally defined as one masquerading as a genuine academic publication but offer little, if any, rigorous peer review. Predatory journals or publishers place a focus on maximising financial profit, as opposed to regulated dissemination of scientific advancements. As a result, authors can often get their work published in such journals with little scrutiny on quality. Although generally warned against and discouraged, universally practiced sanctions against researchers' submission to and publication in predatory journals are not common. Predatory publishing thus remains prevalent, particularly in places where academic success is measured by the quantity rather than quality of publication output, which feeds the journal's business model that thrives upon significant market demand. However, such an undesirable enterprise has the potential to flood the scientific literature with unsound research that could be misleadingly perceived as authoritative. This may result in or add to the confusion of policy makers and the layperson, consequentially bringing disrepute to science and all parties involved. Here, we argue that wilfully submitting one's manuscript to a predatory journal may constitute an active act of avoidance of rigorous peer review of one's work. If such is the intention, it would be a questionable research practice and could be considered an, albeit covert, form of scientific misconduct. If labelled as such, and with institutional and funding rules erected to discourage the practice, predatory publishing could be effectively put out of business through diminishing the consumer demand.
{"title":"Wilfully submitting to and publishing in predatory journals - a covert form of research misconduct?","authors":"Nicole Shu Ling Yeo-Teh, Bor Luen Tang","doi":"10.11613/BM.2021.030201","DOIUrl":"10.11613/BM.2021.030201","url":null,"abstract":"<p><p>A predatory journal could be provisionally defined as one masquerading as a genuine academic publication but offer little, if any, rigorous peer review. Predatory journals or publishers place a focus on maximising financial profit, as opposed to regulated dissemination of scientific advancements. As a result, authors can often get their work published in such journals with little scrutiny on quality. Although generally warned against and discouraged, universally practiced sanctions against researchers' submission to and publication in predatory journals are not common. Predatory publishing thus remains prevalent, particularly in places where academic success is measured by the quantity rather than quality of publication output, which feeds the journal's business model that thrives upon significant market demand. However, such an undesirable enterprise has the potential to flood the scientific literature with unsound research that could be misleadingly perceived as authoritative. This may result in or add to the confusion of policy makers and the layperson, consequentially bringing disrepute to science and all parties involved. Here, we argue that wilfully submitting one's manuscript to a predatory journal may constitute an active act of avoidance of rigorous peer review of one's work. If such is the intention, it would be a questionable research practice and could be considered an, albeit covert, form of scientific misconduct. If labelled as such, and with institutional and funding rules erected to discourage the practice, predatory publishing could be effectively put out of business through diminishing the consumer demand.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030201"},"PeriodicalIF":3.8,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39311865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Müjgan Ercan, Emiş Deniz Akbulut, Nihayet Bayraktar, Şerif Ercan
Introduction: The current study aimed to assess the interference of in vitro haemolysis on complete blood count (CBC) using Abbott Alinity hq system, and to determine which haemolysis levels affect the reliability of sample results.
Materials and methods: Blood samples obtained from 25 volunteers in K3-EDTA tubes were divided into four aliquots. The first aliquot was not subjected to any intervention. The second, third and fourth aliquots were passed through a fine needle 2, 4 and 6 times, respectively. Complete blood count was performed by multi-angle polarized scatter separation technology and haemolysis index (HI) was assessed from the plasma samples separated by centrifugation. Five groups were formed according to the HI values. The percentage biases between the results of non-haemolysed and haemolysed groups were compared with the desirable bias limits from The European Federation of Clinical Chemistry and Laboratory Medicine database and reference change values (RCVs).
Results: In groups 1 to 4, the effects of haemolysis on CBC parameters were acceptable comparing to the analytical bias except for lymphocytes (7.26%-7.42%), MCH (2.59%), and MCHC (0.47%-2.81%). Results of group 5 (gross haemolysis) showed decreases in HCT(- 4.56%), RBC (- 4.07%) count and increase in lymphocyte (11.60%) count higher than the analytical performance specifications. Moreover, variations in MCH (4.65%) and MCHC (5.24%) were exceeding the RCVs.
Conclusions: Gross haemolysis (haemoglobin concentration > 10 g/L) is likely to produce unreliable CBC results on non-pathological samples. Further studies including pathological specimens are needed.
{"title":"Effects of specimen haemolysis on complete blood count results by Abbott Alinity hq System.","authors":"Müjgan Ercan, Emiş Deniz Akbulut, Nihayet Bayraktar, Şerif Ercan","doi":"10.11613/BM.2021.030706","DOIUrl":"https://doi.org/10.11613/BM.2021.030706","url":null,"abstract":"<p><strong>Introduction: </strong>The current study aimed to assess the interference of <i>in vitro</i> haemolysis on complete blood count (CBC) using Abbott Alinity hq system, and to determine which haemolysis levels affect the reliability of sample results.</p><p><strong>Materials and methods: </strong>Blood samples obtained from 25 volunteers in K3-EDTA tubes were divided into four aliquots. The first aliquot was not subjected to any intervention. The second, third and fourth aliquots were passed through a fine needle 2, 4 and 6 times, respectively. Complete blood count was performed by multi-angle polarized scatter separation technology and haemolysis index (HI) was assessed from the plasma samples separated by centrifugation. Five groups were formed according to the HI values. The percentage biases between the results of non-haemolysed and haemolysed groups were compared with the desirable bias limits from The European Federation of Clinical Chemistry and Laboratory Medicine database and reference change values (RCVs).</p><p><strong>Results: </strong>In groups 1 to 4, the effects of haemolysis on CBC parameters were acceptable comparing to the analytical bias except for lymphocytes (7.26%-7.42%), MCH (2.59%), and MCHC (0.47%-2.81%). Results of group 5 (gross haemolysis) showed decreases in HCT(- 4.56%), RBC (- 4.07%) count and increase in lymphocyte (11.60%) count higher than the analytical performance specifications. Moreover, variations in MCH (4.65%) and MCHC (5.24%) were exceeding the RCVs.</p><p><strong>Conclusions: </strong>Gross haemolysis (haemoglobin concentration > 10 g/L) is likely to produce unreliable CBC results on non-pathological samples. Further studies including pathological specimens are needed.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 3","pages":"030706"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39527908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}